• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国1929 - 1971年首次安非他明流行:对当前有启示意义的定量与定性回顾。

America's first amphetamine epidemic 1929-1971: a quantitative and qualitative retrospective with implications for the present.

作者信息

Rasmussen Nicolas

机构信息

History & Philosophy of Science, Room 314 Morven Brown, University of New South Wales, Sydney NSW 2052 Australia.

出版信息

Am J Public Health. 2008 Jun;98(6):974-85. doi: 10.2105/AJPH.2007.110593. Epub 2008 Apr 29.

DOI:10.2105/AJPH.2007.110593
PMID:18445805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2377281/
Abstract

Using historical research that draws on new primary sources, I review the causes and course of the first, mainly iatrogenic amphetamine epidemic in the United States from the 1940s through the 1960s. Retrospective epidemiology indicates that the absolute prevalence of both nonmedical stimulant use and stimulant dependence or abuse have reached nearly the same levels today as at the epidemic's peak around 1969. Further parallels between epidemics past and present, including evidence that consumption of prescribed amphetamines has also reached the same absolute levels today as at the original epidemic's peak, suggest that stricter limits on pharmaceutical stimulants must be considered in any efforts to reduce amphetamine abuse today.

摘要

利用基于新一手资料的历史研究,我回顾了美国20世纪40年代至60年代首次主要由医源性导致的安非他明流行的起因和过程。回顾性流行病学表明,如今非医疗用途兴奋剂使用以及兴奋剂依赖或滥用的绝对流行率已接近1969年左右该流行高峰期的水平。过去与现在的流行情况之间存在更多相似之处,包括有证据表明,如今处方安非他明的消费量也达到了最初流行高峰期的绝对水平,这表明在当今任何减少安非他明滥用的努力中,都必须考虑对药用兴奋剂实施更严格的限制。

相似文献

1
America's first amphetamine epidemic 1929-1971: a quantitative and qualitative retrospective with implications for the present.美国1929 - 1971年首次安非他明流行:对当前有启示意义的定量与定性回顾。
Am J Public Health. 2008 Jun;98(6):974-85. doi: 10.2105/AJPH.2007.110593. Epub 2008 Apr 29.
2
Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses.苯丙胺类兴奋剂:其医学和非医学用途的早期历史
Int Rev Neurobiol. 2015;120:9-25. doi: 10.1016/bs.irn.2015.02.001. Epub 2015 Mar 17.
3
Methamphetamine: here we go again?甲基苯丙胺:我们又来了?
Addict Behav. 2011 Dec;36(12):1168-73. doi: 10.1016/j.addbeh.2011.07.017. Epub 2011 Jul 22.
4
Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.在退伍军人事务部,处方兴奋剂药物新使用者出现苯丙胺使用障碍和死亡的风险。
Addiction. 2018 May;113(5):857-867. doi: 10.1111/add.14122. Epub 2018 Jan 9.
5
[Substitution therapy tested against amphetamine dependence].[针对苯丙胺依赖的替代疗法测试]
Lakartidningen. 2016 Jan 6;113:DSU6.
6
Amphetamine-related disorders.
J La State Med Soc. 1998 Oct;150(10):491-9.
7
Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions.美国非医疗处方药物使用及药物使用障碍的患病率、相关因素及共病情况:酒精及相关状况全国流行病学调查结果
J Clin Psychiatry. 2006 Jul;67(7):1062-73. doi: 10.4088/jcp.v67n0708.
8
Clinical effects and management of methamphetamine abuse.甲基苯丙胺滥用的临床效应与处理
Pharmacotherapy. 2006 Aug;26(8):1148-56. doi: 10.1592/phco.26.8.1148.
9
Is America's meth scourge really coming to an end?美国的冰毒祸害真的要结束了吗?
MedGenMed. 2006 Dec 22;8(4):62.
10
Potential adverse effects of amphetamine treatment on brain and behavior: a review.苯丙胺治疗对大脑和行为的潜在不良影响:综述
Mol Psychiatry. 2009 Feb;14(2):123-42. doi: 10.1038/mp.2008.90. Epub 2008 Aug 12.

引用本文的文献

1
Stimulant medications affect arousal and reward, not attention.刺激性药物影响唤醒和奖赏,而非注意力。
bioRxiv. 2025 May 22:2025.05.19.654915. doi: 10.1101/2025.05.19.654915.
2
Amphetamines: a current epidemic.安非他命:当前的一种流行毒品。
Front Psychiatry. 2025 Mar 25;16:1460341. doi: 10.3389/fpsyt.2025.1460341. eCollection 2025.
3
The metabolic and cardiovascular effects of amphetamine are partially mediated by the central melanocortin system.苯丙胺的代谢和心血管效应部分由中枢黑皮质素系统介导。
Cell Rep Med. 2025 Feb 18;6(2):101936. doi: 10.1016/j.xcrm.2025.101936. Epub 2025 Feb 5.
4
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.美国中枢神经系统兴奋剂使用者的医疗用途和联合药物治疗:一项横断面分析。
BMJ Open. 2023 Apr 24;13(4):e069668. doi: 10.1136/bmjopen-2022-069668.
5
Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis.多种促醒药物治疗发作性睡病日间过度嗜睡的疗效与安全性比较:网状Meta分析
Nat Sci Sleep. 2023 Apr 14;15:217-230. doi: 10.2147/NSS.S404113. eCollection 2023.
6
Biopolymeric Coatings for Local Release of Therapeutics from Biomedical Implants.生物医用植入物局部释药的高分子涂层
Adv Sci (Weinh). 2023 Apr;10(12):e2207603. doi: 10.1002/advs.202207603. Epub 2023 Feb 13.
7
Stimulant misuse among youth.青少年兴奋剂滥用。
Curr Probl Pediatr Adolesc Health Care. 2022 Sep;52(9):101265. doi: 10.1016/j.cppeds.2022.101265. Epub 2022 Sep 29.
8
Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.新型精神活性物质:治疗潜力与精神活性娱乐性滥用之间的微妙界限。
Medicines (Basel). 2022 Mar 1;9(3):19. doi: 10.3390/medicines9030019.
9
Should local drug delivery systems be used in dentistry?牙科是否应该使用局部药物递送系统?
Drug Deliv Transl Res. 2022 Jun;12(6):1395-1407. doi: 10.1007/s13346-021-01053-x. Epub 2021 Sep 20.
10
Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study.美国成年人中枢神经系统兴奋剂医疗使用的变化:2013 年和 2018 年的横断面研究。
BMJ Open. 2021 Aug 13;11(8):e048528. doi: 10.1136/bmjopen-2020-048528.

本文引用的文献

1
Oral use of stimulants obtained from inhalers.口服从吸入器中获取的兴奋剂。
J Am Med Assoc. 1947 Dec 6;135(14):909-15. doi: 10.1001/jama.1947.02890140029007.
2
Ice: a new dosage form of an old drug.冰:一种老药的新剂型。
Science. 1990 Aug 10;249(4969):631-4. doi: 10.1126/science.249.4969.631.
3
Making the first anti-depressant: amphetamine in American medicine, 1929-1950.制造第一种抗抑郁药:1929年至1950年美国医学中的安非他明。
J Hist Med Allied Sci. 2006 Jul;61(3):288-323. doi: 10.1093/jhmas/jrj039. Epub 2006 Feb 21.
4
Anorectics on trial: a half century of federal regulation of prescription appetite suppressants.接受试验的食欲抑制剂:联邦对处方类食欲抑制剂监管的半个世纪
Ann Intern Med. 2005 Sep 6;143(5):380-5. doi: 10.7326/0003-4819-143-5-200509060-00013.
5
DRUGS, NEUROSIS AND THE FAMILY PHYSICIAN.药物、神经症与家庭医生
Calif Med. 1965 Jan;102(1):5-8.
6
Amphetamines in general practice.普通医疗实践中的苯丙胺类药物。
J Coll Gen Pract. 1962 Nov;5(4):603-6.
7
EXPERT committee on addiction-producing drugs; seventh report.成瘾性药物专家委员会;第七次报告。
World Health Organ Tech Rep Ser. 1957(116):1-15.
8
Treatment of mild depressions in general office practice.
J Am Med Assoc. 1957 Jun 1;164(5):516-8. doi: 10.1001/jama.1957.02980050006002.
9
Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk.儿童期破坏性行为障碍与青年期物质使用及依赖症状之间的关系:患有注意力缺陷/多动障碍和品行障碍症状的个体面临独特风险。
Psychol Addict Behav. 2003 Jun;17(2):151-8. doi: 10.1037/0893-164x.17.2.151.
10
FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey Amendment of 1951.
Pharm Hist. 1994;36(2):55-70.